Health

  • June 17, 2026

    DC Judge Halts Prison Bureau's 'Near Total' Trans Care Ban

    A Washington, D.C., federal judge blocked the Bureau of Prisons from enforcing a "near total ban" on gender-affirming care for trans incarcerated people, ruling Wednesday the policy was "reverse engineered" to fit the Trump administration's directive barring funding of such care in prisons, violating the Administrative Procedure Act. 

  • June 17, 2026

    Medline, AdaptHealth Sued Over Deadly Hospital Bed Fire

    Medline Industries and AdaptHealth have been sued by the estate and daughter of a Connecticut woman who allegedly died after suffering burns over 47% of her body when an electric-powered hospital-style bed caught fire in a Newtown home.

  • June 17, 2026

    Sen. Committee Clears Drug Disclosure, Biosimilar Bills

    The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need for more interchangeable biosimilars.

  • June 17, 2026

    FTC Claims Trans Health Org. Lied About Medical Consensus

    The Federal Trade Commission and several Republican-led states sued the World Professional Association for Transgender Health on Wednesday, telling a Texas federal court that the organization falsely touted a "medical consensus" while advocating for transgender healthcare for children.

  • June 17, 2026

    J&J Can't Get New Trial In $65.5M Minn. Talc Cancer Case

    A Minnesota state judge on Wednesday denied Johnson & Johnson's bid for a new trial in a case that resulted in a $65.5 million verdict in favor of a 37-year-old wife and mother who claimed that the company's talc baby powder caused her cancer, rejecting arguments about her husband's infidelity.

  • June 17, 2026

    ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review

    Masimo Corp. and the U.S. International Trade Commission have pushed back on Apple's request for full Federal Circuit rehearing of a panel decision finding an older version of the Apple Watch infringes Masimo's patents, saying Wednesday the case isn't exceptional enough for such scrutiny.

  • June 17, 2026

    Aetna Can't Bring Its Own Claims In $20M Air Ambulance Fight

    A Connecticut federal judge has agreed to throw out three Aetna entities' allegations that air ambulance operators misrepresented their services throughout an Independent Dispute Resolution award process, finding that the federal No Surprises Act bars the insurer's counterclaims.

  • June 17, 2026

    6th Circ. OKs 30-Month Medical Fraudster Kickback Sentence

    The Sixth Circuit has ruled in a published opinion that a 30-month prison sentence was correctly calculated for a Tennessee man who was convicted of violating federal anti-kickback laws with his fraudulent door-to-door medical marketing firm.

  • June 17, 2026

    DOJ's Pot Shift Leaves Key Questions For Cannabis Industry

    The Trump administration's recent moves to relax federal restrictions on marijuana through the administrative process will have unclear ramifications for all industry players unless Congress steps in to rewrite cannabis law, attorneys heard Wednesday.

  • June 17, 2026

    Glenmark Pharma Beats Suit Over Recalled Cholesterol Drugs

    A New Jersey federal judge Wednesday tossed a proposed class action that accused drugmaker Glenmark Pharmaceuticals of falsely representing that its statin cholesterol drugs were safe and effective despite a recall over its manufacturing practices, saying plaintiff consumers' lack of actual economic or physical injury meant they couldn't sue.

  • June 17, 2026

    NC Clinic, School District Must Face COVID Vax Challenge

    A North Carolina state appeals panel issued its second opinion in a lawsuit from the mother of a teenager who alleged he was vaccinated for COVID against his will, finding Wednesday that she adequately put forward constitutional claims and can pursue allegations against a school district and medical society clinic in trial court.

  • June 17, 2026

    DOJ Deal Bars OhioHealth From Blocking Patient Steering

    OhioHealth swore off contract language inhibiting the ability of insurers to steer patients to cheaper healthcare providers, in a settlement resolving one of two U.S. Department of Justice antitrust lawsuits targeting alleged hospital network efforts to force insurers to cover their hospitals in all plans.

  • June 17, 2026

    HHS Urges DC Court To Toss AbbVie 340B Audit Challenge

    A D.C. federal court should toss a suit by AbbVie challenging the U.S. Department of Health and Human Services' interpretation of who qualifies as a "patient" for audits under the federal 340B drug discount program, HHS said in a motion, arguing the court lacks jurisdiction.

  • June 17, 2026

    Opioid Clinic To Pay $10M To Resolve False Treatment Claims

    A Rhode Island opioid treatment provider and its former CEO have agreed to pay $10.2 million to resolve allegations they billed Medicaid and Medicare for treatments they did not provide, according to the U.S. Department of Justice.

  • June 17, 2026

    Doctors Defeat Most Claims In Life Insurance Fraud Dispute

    A life insurer failed to adequately allege that a pair of doctors were knowingly involved in a purported scheme to defraud the carrier into issuing $160 million worth of policies, a New Jersey federal court ruled, tossing all but one claim brought under the state's Insurance Fraud Protection Act.

  • June 17, 2026

    Lab Owner Avoids 'Very Long' Prison Term For $89M Fraud

    A Utah businessman who cooperated with prosecutors after admitting his role in a false Medicare claims scheme was sentenced Wednesday in New Jersey federal court to three years of probation and ordered to forfeit $28 million.

  • June 17, 2026

    Medical Spa Investment Co. Files Ch. 11 With $10M+ Debt

    An investment management firm specializing in medical spas and medical aesthetics providers has filed for Chapter 11 protection in Delaware with $10 million to $50 million in debt.

  • June 17, 2026

    Mangione To Use 'Mental Defect' Defense In NY Murder Trial

    A New York state judge revealed Wednesday that Luigi Mangione will argue he was suffering a "mental defect" at the time he allegedly murdered UnitedHealthcare CEO Brian Thompson.

  • June 16, 2026

    Feds Say NY Health Officials Aided Fraud In Medicaid Program

    New York health officials rigged the bidding process for managing the state's $10 billion Medicaid homecare program, and the state-chosen steward didn't deliver on its promises, which has harmed patients and caregivers and cost American taxpayers millions of dollars, the U.S. Department of Justice alleged in a lawsuit Tuesday.

  • June 16, 2026

    Wash. Judge Won't Revisit Order On Ed. Dept. School Grants

    A federal judge in Seattle will not reconsider her decision declining to enforce an earlier order barring the U.S. Department of Education from ceasing school mental health grants, saying Washington and other plaintiff states have not shown that the court erred.

  • June 16, 2026

    Ga. Justices Uphold $42M Verdict In Hospital Death Suit

    The Georgia Supreme Court refused to grant a new trial or lower a $42 million jury verdict in a wrongful death case filed by the fiance and estate of a woman who died in the hospital after giving birth to her daughter by cesarean section.

  • June 16, 2026

    Sanofi Sued Over Qunol CoQ10 'Superior Absorption' Claims

    Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows otherwise and prior legal action that barred it from making similar efficacy claims, alleges a proposed class action filed Monday in New Jersey federal court.

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

  • June 16, 2026

    WestRock Must Face Class Claims Over Wash. Paper Mill Odor

    A group of Washington and Oregon residents can proceed with a proposed class action accusing paper mill operator WestRock Longview LLC of negligently releasing noxious gases that sickened neighbors and hurt property values, a Washington federal judge ruled Monday.

  • June 16, 2026

    J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case

    A Minnesota state judge on Monday upheld a $65.5 million verdict awarded to a mother of three children who had claimed that Johnson & Johnson's talc products exposed her to asbestos and contributed to her cancer, saying that the jury's decision was supported by the evidence at trial.

Expert Analysis

  • Series

    Speed Jigsaw Puzzling Makes Me A Better Lawyer

    Author Photo

    My passion for speed puzzling — I can complete a 500-piece jigsaw puzzle in under 50 minutes — has sharpened my legal skills in more ways than one, with both disciplines requiring patience, precision and the ability to keep the bigger picture in mind while working through the details, says Tazia Statucki at Proskauer.

  • Documenting Business Purpose After IRS' 10th Circ. Win

    Author Photo

    Following the Tenth Circuit’s recent Liberty Global v. U.S. decision, which held the economic substance doctrine does not require a threshold relevancy determination, taxpayers can prepare for potential audits by maintaining contemporaneous documentation and taking other steps that demonstrate the business purpose of transactions, say attorneys at Crowell & Moring.

  • How Oregon Ruling Affects Federal Gender Care Crackdown

    Author Photo

    In a favorable development for healthcare providers, an Oregon federal court recently vacated certain U.S. Department of Health and Human Services restrictions on gender-affirming care for minors, but the government's broader campaign against this care, including proposed rulemaking and agency investigations, leaves significant uncertainty, say attorneys at Arnold & Porter.

  • Suit's Dismissal Would Not Settle Gold Card Visa's Legality

    Author Photo

    The government’s recent assertion that the plaintiffs in American Association of University Professors v. Department of Homeland Security lack standing to challenge the Trump administration’s pay-to-play immigration program does not address whether an agency can deem a million-dollar gift evidence of eligibility for immigration benefits carefully defined by Congress, says Jun Li at Reid & Wise.

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • NY Opioid Antagonist Mandate Leaves Employers Guessing

    Author Photo

    A recently enacted New York law will require employers that are federally mandated to maintain first-aid supplies to now include an opioid antagonist, but being that it is subject to a complicated Occupational Safety and Health Administration analysis, employers face several unanswered compliance questions, say attorneys at Conn Maciel.

  • Calif. Case Raises Questions For Medical Practice Investors

    Author Photo

    The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's response highlight how the California appeals court's ruling could significantly affect the structure and enforceability of succession arrangements in medical practice ownership, say attorneys at Ropes & Gray.

  • Previewing FDA Preapproval Access In Psychedelics EO

    Author Photo

    The second of two pathways for psychedelic drug access outlined in President Donald Trump's recent executive order constitutes an unprecedented expansion of the Right to Try Act, which could fundamentally alter the psychedelic access landscape while presenting significant regulatory, operational and legal challenges, say attorneys at Husch Blackwell.

  • Previewing FDA National Priority Vouchers In Psychedelics EO

    Author Photo

    President Donald Trump's recent executive order on psychedelic drug access represents a watershed moment in federal drug policy, but its significance lies in two distinct regulatory pathways, the first being the Commissioner's National Priority Vouchers, which offer a significant opportunity to compress U.S. Food and Drug Administration review, say Kimberly Chew at Husch Blackwell and Odette Hauke at Odette Alina.

  • Series

    Playing Magic: The Gathering Makes Me A Better Lawyer

    Author Photo

    The competitive card game Magic: The Gathering offers me a training ground for the strategic thinking skills crucial to litigation, challenging me to adapt to oft-updated rules, analyze text as complicated as any statute and anticipate my opponent’s next moves, says Christopher Smith at Lash Goldberg.

  • Why Product-Based Public Nuisance Claims May Be Waning

    Author Photo

    The Maryland Supreme Court's recent decision in Express Scripts v. Anne Arundel County is the latest in a national trend of rulings rejecting product-based public nuisance claims — but other forms of government litigation against companies that allegedly increase the cost of public services are likely to continue, say attorneys at Simpson Thacher.

  • What's At Stake For Employers In Fight Over Visa Pause

    Author Photo

    For employers that rely on foreign talent, the Trump administration’s suspension of immigrant visa issuance for the nationals of 75 countries is creating practical problems, and a recently filed lawsuit challenging the pause could determine whether consular processing, for some, ceases to be an individualized process, says attorney Lisa Eisenberg.

  • Improving Well-Being In Law, 10 Years After Landmark Study

    Author Photo

    An important 2016 study revealed significant substance abuse and mental health issues among lawyers, and while the findings helped normalize the conversation around these topics, a decade later, structural change is still needed, says Denise Robinson at PLI.

  • How To Gear Up For Trump's Pharma Tariffs

    Author Photo

    President Donald Trump's proclamation establishing tariffs on certain pharmaceutical products holds a few areas of ambiguity that companies should review and prepare for before the tariffs come into effect later this year, say attorneys at Arnold & Porter.

  • AG Watch: Texas Charts A Course On Investigative Authority

    Author Photo

    The Texas Supreme Court's recent decision in Texas v. PFLAG affirmed, and arguably expanded, the Texas attorney general's civil investigative demand authority, providing a road map that other courts evaluating state attorney general CIDs may find instructive, amid a lack of precedent, say attorneys at Kelley Drye.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.